Atara Biotherapeutics (ATRA) Interest Coverage Ratio Growth (3y) (2017 - 2026)
Atara Biotherapeutics (ATRA) Interest Coverage Ratio Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,827.19 Bn | 1,827.13 Bn | - | - |
| 2 | Akari Therapeutics | 1,006.47 Bn | 1,006.47 Bn | - | - |
| 3 | BeOne Medicines | 475.45 Bn | 470.65 Bn | 1.35 Bn | 28.11% |
| 4 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | -6.89% |
| 5 | Regeneron Pharmaceuticals | 71.31 Bn | 62.56 Bn | 3.31 Bn | 79.27% |
| 6 | Belite Bio | 62.61 Bn | 62.61 Bn | - | - |
| 7 | Argenx Se | 55.56 Bn | 50.38 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 37.96 Bn | 34.96 Bn | 959.66 Mn | 40.09% |
| 9 | Revolution Medicines | 37.20 Bn | 37.20 Bn | - | 29.47% |
| 10 | Atara Biotherapeutics | 109.27 Mn | 100.91 Mn | 392,000.00 | 58.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.34% |
| Dec 31, 2025 | 44.32% |
| Sep 30, 2025 | 13.75% |
| Jun 30, 2025 | 27.52% |
| Mar 31, 2025 | 27.22% |
| Dec 31, 2024 | 90.35% |
| Sep 30, 2024 | -71.24% |
| Jun 30, 2024 | -28.60% |
| Mar 31, 2024 | 8.76% |
| Dec 31, 2023 | 45.11% |
| Sep 30, 2023 | -38.59% |
| Jun 30, 2023 | -76.50% |
| Mar 31, 2023 | 76.62% |
| Dec 31, 2022 | 61.58% |
| Sep 30, 2022 | 29.95% |
| Jun 30, 2022 | 10.10% |
| Mar 31, 2022 | -456.56% |
| Dec 31, 2021 | -226.42% |
| Sep 30, 2021 | -77.74% |
| Jun 30, 2021 | -112.88% |